Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Drug efficacy

Non-aspirin NSAIDs outperform aspirin for colorectal cancer prevention

Non-aspirin NSAIDs offer protection against colorectal cancer but carry a high risk of adverse events.

Research has indicated that non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, have a protective effect against the development of colorectal cancer in patients with previous neoplasia. But the relative efficacy of different pharmaceutical agents is unknown.

To seek clarity, researchers performed a network meta-analysis of data from 14 clinical trials involving 12,234 patients who had previously been treated for colorectal polyps or cancer.

Reporting in The BMJ[1], they found that, compared with placebo, non-aspirin NSAIDs were superior for preventing advanced metachronous neoplasia over follow-up of three to five years. Low-dose aspirin was ranked second for efficacy, but had the most favourable risk-benefit profile.

As non-aspirin NSAIDs carry a high risk of serious adverse events, the authors suggest that low-dose aspirin might therefore be preferable for all patients except those with previous high-risk neoplasia.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202251

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Close up of aspirin tablets

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.